SCHEMBL13007276

SCHEMBL13007276

Cn1ccc2cc(CO)c(O)cc2c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 2/20 0.40
BRD9 Q9H8M2 2/20 0.36
BRD4 O60885 2/20 0.36
TAF1 P21675 1/20 0.36
BRPF1 P55201 1/20 0.36
CREBBP Q92793 1/20 0.36
CECR2 Q9BXF3 1/20 0.36
PKM P14618 1/20 0.36
CDK4 P11802 4/20 0.35
CCND1 P24385 4/20 0.35
GAA P10253 1/20 0.35
MCL1 Q07820 1/20 0.34
TP53 P04637 2/20 0.33
MIF P14174 1/20 0.33
KLF10 Q13118 1/20 0.33
CCNE2 O96020 2/20 0.33
CCNE1 P24864 2/20 0.33
CDK2 P24941 2/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13007272 0.94 TNF (0.40) TNFBRD9BRD4TAF1BRPF1
SCHEMBL26409406 0.83 TNF (0.49) TNFBRD9BRD4TAF1BRPF1
SCHEMBL13007285 0.80 TNF (0.38) TNFBRD9BRD4TAF1BRPF1
SCHEMBL14106255 0.79 TNF (0.47) TNFBRD9BRD4TP53MAPT
SCHEMBL13007287 0.77 TNF (0.38) TNFBRD9BRD4TAF1BRPF1
SCHEMBL3770428 0.75 TNF (0.46) TNFPKMGAAMCL1CDK2
SCHEMBL28928364 0.74 BRD9 (0.41) TNFBRD9BRD4TAF1BRPF1
SCHEMBL30186388 0.74 BRD9 (0.41) TNFBRD9BRD4TAF1BRPF1
SCHEMBL30617770 0.73 BRD4 (0.42) BRD9BRD4TAF1BRPF1CREBBP
SCHEMBL3768022 0.72 TNF (0.46) TNFPKMGAAMCL1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 MTNR1A, MTNR1B, MC2R TNF 3844/4885BRD9 454/4885BRD4 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.